iPS heart therapy could enter human trials
Osaka University researchers prepare to apply for permission to be the first in the world to test an iPS cell heart disease treatment on human patients.
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
Osaka University researchers prepare to apply for permission to be the first in the world to test an iPS cell heart disease treatment on human patients.
© Nippon Television Network Corporation